This federal contract award, valued at $45,829.15, was issued by the Department of Veterans Affairs (VA) to Ferring Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The award is a delivery order against Ferring's multiple-award indefinite-delivery vehicle (IDV) on the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), valued at $98.2 million over five years. Through this contract, Ferring will provide the VA with Adstiladrin (nadofaragene firadenovec), a treatment for genitourinary cancers, to support the VA's provision of healthcare services to veterans. This delivery order is for a firm-fixed price with no set-aside designation. Ferring will fulfill the order from its facility in Parsippany, New Jersey, with delivery to the VA's Carrollton, Texas location. The contract has an ultimate completion date of January 17, 2025.
Generated 1/17/25, 9:28 AM